Dr. Hiroshi Petit

Renal pathologist · MD Anderson Cancer Center · United States (US) · Nephrology

Tier 1STK-0094GoodOwner MSL ABDr. Anna Becker

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Glomerular disease
Disease interests: FSGS, IGAN
Scientific interests: APRIL pathwaySurrogate endpoints
Engagement preference: Virtual
Advisory boards: 3
Publications: 40
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 1: 4 per year (assumption)

Last engaged: 14 Apr 2026 (154 days ago)
Next planned contact: 14 Jul 2026 Overdue
Last 6 months vs target: 50%
1 of 2 expected engagements

Insights from this stakeholder (2)

INS-0049Patient-reported outcomes
15 Apr 2026 · Unmet medical need
HighClosed
INS-0027Proteinuria as surrogate endpoint
07 Jan 2026 · Patient experience
MediumClosed

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
14 Apr 2026	Scientific exchange	Virtual	Dr. Anna Becker	Nephrada	Patient-reported outcomesProteinuria as surrogate endpoint+1	1	—	Reviewed	ENG-0142
07 Jan 2026	Congress meeting	Phone	Dr. Anna Becker	Nephrada	Proteinuria as surrogate endpoint	1	—	Reviewed	ENG-0125

Timeline

14 Apr 2026
Scientific exchange
Patient-reported outcomes, Proteinuria as surrogate endpoint, Treatment burden and fatigue
07 Jan 2026
Congress meeting
Proteinuria as surrogate endpoint

Related stakeholders (4)

MD Anderson Cancer Center

Dr. Valentina Nakamura
Community nephrologist
Tier 1
Dr. Farah Fischer
Primary care physician
Tier 2
Dr. Ingrid Castellano
Dermatologist
Tier 3
Dr. Javier Petit
Dermatologist
Tier 2